RT Book, Section A1 Boucher, Bradley A. A1 Wood, G. Christopher A2 Chisholm-Burns, Marie A. A2 Schwinghammer, Terry L. A2 Malone, Patrick M. A2 Kolesar, Jill M. A2 Bookstaver, P. Brandon A2 Lee, Kelly C. SR Print(0) ID 1187008113 T1 Circulatory Shock Syndromes T2 Pharmacotherapy Principles & Practice, 6e YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781260460278 LK ppp.mhmedical.com/content.aspx?aid=1187008113 RD 2024/03/28 AB LEARNING OBJECTIVESUpon completion of the chapter, the reader will be able to:List the most common conditions resulting in the following circulatory shock syndromes: hypovolemic, cardiogenic, and obstructive.Describe the major hemodynamic and metabolic abnormalities that occur in patients with circulatory shock.Describe the clinical presentation including signs, symptoms, and laboratory test measurements for the typical circulatory shock patient.Prepare a treatment plan with clearly defined outcome criteria for hypovolemic, cardiogenic, and obstructive shock patients, including fluid management, pharmacologic therapy, and/or surgical/mechanical interventions.Compare and contrast relative advantages and disadvantages of crystalloids, colloids, and blood products in treating hypovolemic shock.Formulate a stepwise monitoring strategy for patients with hypovolemic, cardiogenic, and obstructive shock.